Irinotecan and Temozolomide for Advanced Ewing Sarcoma After Failure of Standard Multimodal Therapy
Phase of Trial: Phase II
Latest Information Update: 02 May 2019
Price : $35 *
At a glance
- Drugs Irinotecan (Primary) ; Temozolomide (Primary) ; Vincristine (Primary)
- Indications Ewing's sarcoma
- Focus Therapeutic Use
- 28 Apr 2019 Active comparator arm added as 5d x 2 VIT (irinotecan, temozolomide and vincristine) to explore the activity of 5-d shorter schedule of VIT and 5-d x2w longer schedule of VIT.
- 28 Apr 2019 Planned number of patients changed from 22 to 102.
- 05 Mar 2018 Planned number of patients changed from 37 to 22.